Compare MOLN & BYRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MOLN | BYRN |
|---|---|---|
| Founded | 2004 | 2005 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Machinery/Components |
| Sector | | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 154.2M | 136.3M |
| IPO Year | 2021 | 2013 |
| Metric | MOLN | BYRN |
|---|---|---|
| Price | $4.25 | $4.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | $8.38 | ★ $23.17 |
| AVG Volume (30 Days) | 951.0 | ★ 838.4K |
| Earning Date | 05-12-2026 | 04-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $16,566,295.00 |
| Revenue This Year | N/A | $4.98 |
| Revenue Next Year | $374.07 | $16.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1692.08 |
| 52 Week Low | $3.53 | $3.17 |
| 52 Week High | $5.36 | $30.62 |
| Indicator | MOLN | BYRN |
|---|---|---|
| Relative Strength Index (RSI) | 58.79 | 44.21 |
| Support Level | $4.13 | $3.17 |
| Resistance Level | $4.30 | $5.17 |
| Average True Range (ATR) | 0.03 | 0.30 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 100.00 | 4.37 |
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.
Byrna Technologies Inc is a designer, manufacturer, retailer, and distributor of technological solutions for security situations that do not require the use of lethal force. The company generates its revenue from the United States, South Africa, Europe, South America, Asia, and Canada.